These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

322 related items for PubMed ID: 34996915

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Left atrial strain imaging differentiates cardiac amyloidosis and hypertensive heart disease.
    Rausch K, Scalia GM, Sato K, Edwards N, Lam AK, Platts DG, Chan J.
    Int J Cardiovasc Imaging; 2021 Jan; 37(1):81-90. PubMed ID: 32728989
    [Abstract] [Full Text] [Related]

  • 3. Atrial fibrillation and subtype of atrial fibrillation in cardiac amyloidosis: clinical and echocardiographic features, impact on mortality.
    Sanchis K, Cariou E, Colombat M, Ribes D, Huart A, Cintas P, Fournier P, Rollin A, Carrié D, Galinier M, Maury P, Duparc A, Lairez O, Toulouse Amyloidosis Research Network collaborators.
    Amyloid; 2019 Sep; 26(3):128-138. PubMed ID: 31172799
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Cardiac amyloidosis is not a single disease: a multiparametric comparison between the light chain and transthyretin forms.
    Neculae G, Adam R, Jercan A, Bădeliță S, Tjahjadi C, Draghici M, Stan C, Bax JJ, Popescu BA, Marsan NA, Coriu D, Jurcuț R.
    ESC Heart Fail; 2024 Oct; 11(5):2825-2834. PubMed ID: 38757395
    [Abstract] [Full Text] [Related]

  • 6. Parametric mapping using cardiovascular magnetic resonance for the differentiation of light chain amyloidosis and transthyretin-related amyloidosis.
    Kravchenko D, Isaak A, Zimmer S, Öztürk C, Mesropyan N, Bischoff LM, Voigt M, Ginzburg D, Attenberger U, Pieper CC, Kuetting D, Luetkens JA.
    Eur Heart J Cardiovasc Imaging; 2024 Sep 30; 25(10):1451-1461. PubMed ID: 38912832
    [Abstract] [Full Text] [Related]

  • 7. Differences in the characteristics and contemporary cardiac outcomes of patients with light-chain versus transthyretin cardiac amyloidosis.
    Itzhaki Ben Zadok O, Vaturi M, Vaxman I, Iakobishvili Z, Rhurman-Shahar N, Kornowski R, Hamdan A.
    PLoS One; 2021 Sep 30; 16(8):e0255487. PubMed ID: 34370783
    [Abstract] [Full Text] [Related]

  • 8. Reduced left atrial myocardial deformation irrespective of cavity size: a potential cause for atrial arrhythmia in hereditary transthyretin amyloidosis.
    Henein MY, Suhr OB, Arvidsson S, Pilebro B, Westermark P, Hörnsten R, Lindqvist P.
    Amyloid; 2018 Mar 30; 25(1):46-53. PubMed ID: 29369708
    [Abstract] [Full Text] [Related]

  • 9. Myocardial native T2 measurement to differentiate light-chain and transthyretin cardiac amyloidosis and assess prognosis.
    Ridouani F, Damy T, Tacher V, Derbel H, Legou F, Sifaoui I, Audureau E, Bodez D, Rahmouni A, Deux JF.
    J Cardiovasc Magn Reson; 2018 Aug 16; 20(1):58. PubMed ID: 30115079
    [Abstract] [Full Text] [Related]

  • 10. Cardiac Structural and Functional Consequences of Amyloid Deposition by Cardiac Magnetic Resonance and Echocardiography and Their Prognostic Roles.
    Knight DS, Zumbo G, Barcella W, Steeden JA, Muthurangu V, Martinez-Naharro A, Treibel TA, Abdel-Gadir A, Bulluck H, Kotecha T, Francis R, Rezk T, Quarta CC, Whelan CJ, Lachmann HJ, Wechalekar AD, Gillmore JD, Moon JC, Hawkins PN, Fontana M.
    JACC Cardiovasc Imaging; 2019 May 16; 12(5):823-833. PubMed ID: 29680336
    [Abstract] [Full Text] [Related]

  • 11. Prognostic value of left atrial function in systemic light-chain amyloidosis: a cardiac magnetic resonance study.
    Mohty D, Boulogne C, Magne J, Varroud-Vial N, Martin S, Ettaif H, Fadel BM, Bridoux F, Aboyans V, Damy T, Jaccard A.
    Eur Heart J Cardiovasc Imaging; 2016 Sep 16; 17(9):961-9. PubMed ID: 27194782
    [Abstract] [Full Text] [Related]

  • 12. Clinical features and predictors of atrial fibrillation in patients with light-chain or transthyretin cardiac amyloidosis.
    Papathanasiou M, Jakstaite AM, Oubari S, Siebermair J, Wakili R, Hoffmann J, Carpinteiro A, Hagenacker T, Thimm A, Rischpler C, Kessler L, Rassaf T, Luedike P.
    ESC Heart Fail; 2022 Jun 16; 9(3):1740-1748. PubMed ID: 35178887
    [Abstract] [Full Text] [Related]

  • 13. Defining echocardiographic predictors of outcome in cardiac amyloidosis by subtype.
    Singulane C, Sun D, Hu Z, Lee L, Sarswat N, Emami Neyestanak M, Patel AR, Lang RM, Addetia K.
    Curr Probl Cardiol; 2024 Sep 16; 49(9):102729. PubMed ID: 38945183
    [Abstract] [Full Text] [Related]

  • 14. Noncontrast Magnetic Resonance for the Diagnosis of Cardiac Amyloidosis.
    Baggiano A, Boldrini M, Martinez-Naharro A, Kotecha T, Petrie A, Rezk T, Gritti M, Quarta C, Knight DS, Wechalekar AD, Lachmann HJ, Perlini S, Pontone G, Moon JC, Kellman P, Gillmore JD, Hawkins PN, Fontana M.
    JACC Cardiovasc Imaging; 2020 Jan 16; 13(1 Pt 1):69-80. PubMed ID: 31202744
    [Abstract] [Full Text] [Related]

  • 15. Myocardial Amyloidosis: The Exemplar Interstitial Disease.
    Fontana M, Ćorović A, Scully P, Moon JC.
    JACC Cardiovasc Imaging; 2019 Nov 16; 12(11 Pt 2):2345-2356. PubMed ID: 31422120
    [Abstract] [Full Text] [Related]

  • 16. LEFT ATRIAL FUNCTION AND VOLUME BY MAGNETIC RESONANCE IN PATIENTS WITH HEREDITARY AMYLOIDOSIS.
    Carmona-Ruiz HA, Rosales-Uvera SG, Ulloa-Córdoba IA, Orihuela-Rodríguez O, Santiago-Cerecedo E, González-Duarte A, Vázquez-Lamadrid J.
    Rev Invest Clin; 2019 Nov 16; 71(6):387-392. PubMed ID: 31823968
    [Abstract] [Full Text] [Related]

  • 17. Clinical and imaging characteristics of patients with cardiac amyloidosis- a single center observational study.
    Ingebrigtsen A, Saeed S, Larsen TH, Reikvam H.
    Scand J Clin Lab Invest; 2024 May 16; 84(3):193-201. PubMed ID: 38709651
    [Abstract] [Full Text] [Related]

  • 18. Diffusion Tensor Cardiovascular Magnetic Resonance in Cardiac Amyloidosis.
    Khalique Z, Ferreira PF, Scott AD, Nielles-Vallespin S, Martinez-Naharro A, Fontana M, Hawkins P, Firmin DN, Pennell DJ.
    Circ Cardiovasc Imaging; 2020 May 16; 13(5):e009901. PubMed ID: 32408830
    [Abstract] [Full Text] [Related]

  • 19. Diagnostic and prognostic value of the left atrial myopathy evaluation in cardiac amyloidosis using echocardiography.
    Ferkh A, Geenty P, Stefani L, Emerson P, Pham J, Byth K, Boyd AC, Richards D, Taylor MS, Kwok F, Kizana E, Thomas L.
    ESC Heart Fail; 2024 Dec 16; 11(6):4139-4147. PubMed ID: 39129371
    [Abstract] [Full Text] [Related]

  • 20. Natural History and Disease Progression of Early Cardiac Amyloidosis Evaluated by Echocardiography.
    Itzhaki Ben Zadok O, Eisen A, Shapira Y, Monakier D, Iakobishvili Z, Schwartzenberg S, Abelow A, Ofek H, Kazum S, Ben-Avraham B, Hamdan A, Bental T, Sagie A, Kornowski R, Vaturi M.
    Am J Cardiol; 2020 Oct 15; 133():126-133. PubMed ID: 32811652
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.